FDA Plans to Adapt and Regulate Innovative E-Cigarette Products
On the afternoon of September 21, following the conclusion of the forum titled "Everyone's Responsibility: Protecting Minors from Tobacco Use" at the GTNF, 2FIRSTS posed a question to Brian A. King, the Director of the Center for Tobacco Products at the US Food and Drug Administration (FDA): With the rapid development of harm reduction products such as pod-based systems, disposable devices, and open systems, how does the FDA plan to adapt to this evolving category landscape and improve the predictability of regulations?
Brian A. King states that previous generations of nicotine products have not been effective in helping adults quit smoking. In recent years, there have been many innovative e-cigarette products that have been helpful in assisting adult smokers to quit. The FDA shows strong support for this innovation and will strive to adapt to these changes to promote the entry of innovative e-cigarette products into the US market.
Disclaimer:
This article is translated from an original Chinese article available on 2firsts.cn by AI, and has been reviewed and edited by 2FIRSTS's English editorial team. The Chinese original text is the only authoritative source of information. The exclusive copyright and license rights to this article are held by 2FIRSTS Technology Co., Ltd. Any reproduction, reprinting, or redistribution of this article, either in part or in full, requires express written permission from 2FIRSTS and must include clear attribution along with a link to this content. Non-compliance may result in legal action. 2FIRSTS Technology Co., Ltd. reserves the right to pursue legal actions in case of unauthorized use or distribution.
